cost utility - Globe Thesis

Keyword [cost utility] Result: 41 - 60 \| Page: 3 of 4
41.	Cost-utility Analysis Of Insulin Degludec Vs Insulin Glargine For Patients With Type 2 Diabetes In China
42.	Study On The Commonness Of Digestive System Drug Lists In Medical Institutions At All Levels In Anhui Province
43.	An economic evaluation of HIV-associated facial lipoatrophy treatments: A cost-utility analysis
44.	Cost Utility Analysis of Balloon Kyphoplasty and Vertebroplasty in the Treatment of Vertebral Compression Fractures in the United States
45.	A cost-utility analysis of liver resection for malignant tumours: A pilot project
46.	Treatment outcomes of sealants on first permanent molars: Natural history, survivorship, and cost-utility analysis
47.	The Cost-effectiveness Of Preventing Mother-to-child Transmission Of HIV In Liangshan Prefecture,Sichuan Province
48.	Cost-utility Threshold For China From The Demand-Side Perspective
49.	Cost-Utility Analysis Of Dapagliflozin Versus Saxagliptin Treatment As Monotherapy Or Combination Therapy As Add-on To Metformin For Treating Type 2 Diabetes Mellitus
50.	Systematic Review Of Evidence-based Clinical Practice Guidelines And Economic Study For Drug Treatment Of Postmenopausal Osteoporosis
51.	Cost-utility Analysis Of Medication Regimens For Tic Disorders In Children And Adolescents Based On Scales Mapping Methods
52.	Economic Evaluation Of Rotigotine Vs.pramipexole For Parkinson's Disease
53.	Value Evaluation Of Pembrolizumab As A Single Agent In The First-line Treatment Of Advanced Non-small Cell Lung Cancer
54.	Cost-utility Analysis Of PD-1/PD-L1 Inhibitors As First-line Treatment For Advanced Lung Cancer
55.	Pharmacoeconomic Evaluation Of Camrelizumab Plus Chemotherapy In First-line Treatment Of Advanced Non-squamous Non-small-cell Lung Cancer
56.	Clinical Efficacy And Health Hconomics Evaluation Of Acupuncture In The Treatment Of Post-stroke Dysphagia
57.	First-line Treatment With Atezolizumab Plus Nab-paclitaxel For Advanced Triple-negative Breast Cancer: A Cost-utility Analysis
58.	A Comparative Study Of EQ-5D-Y And CHU-9D In Measuring The Health Utility Of Children With Allergic Rhinitis
59.	Pharmacoeconomic Evaluation Of Rosuvastatin In Primary Prevention Of Cardiovascular Disease
60.	Cost-utility Analysis Of Neonatal Hepatitis B Vaccine Immunization Planning Strategies In Beijing From 1992 To 2013
<<First <Prev Next> Last>> Jump to